Beverly Mock | Academic Influence

Beverly Mock's AcademicInfluence.com Rankings

Beverly Mock

Biology

#14793

World Rank

#18645

Historical Rank

#2918

USA Rank

Genetics

#1819

World Rank

#1934

Historical Rank

#351

USA Rank

Molecular Biology

#2737

World Rank

#2779

Historical Rank

#313

USA Rank

biology Degrees

Download Badge

Biology

Beverly Mock's Degrees

Bachelors Biology University of California, Berkeley
Masters Genetics Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Beverly Mock Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Beverly Anne Mock is an American geneticist who is a deputy director of the National Cancer Institute's Center for Cancer Research. Life Mock obtained a Ph.D. in zoology from the University of Maryland, College Park in 1983. Her dissertation was titled, The population biology of Trypanosoma diemyctyli. She continued her studies on the genetics of susceptibility to parasitic diseases in the department of immunology at the Walter Reed Army Institute of Research.

(See a Problem?)

Beverly Mock's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Collaborative Cross, a community resource for the genetic analysis of complex traits (2004) (921)
The nature and identification of quantitative trait loci: a community's view (2003) (388)
Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection (1989) (318)
Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. (2013) (260)
Interleukin 6 is essential for in vivo development of B lineage neoplasms (1995) (235)
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. (1998) (144)
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. (2011) (117)
Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. (1994) (110)
Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility (1995) (103)
Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression (2015) (101)
Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. (1993) (94)
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex (2018) (93)
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression (2011) (92)
Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. (1994) (87)
Hormonal modulation of sex differences in resistance to Leishmania major systemic infections (1988) (85)
Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility (2001) (82)
p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB (2003) (78)
Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). (1994) (78)
B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses (2013) (77)
Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position. (1987) (68)
The murine Il-6 gene maps to the proximal region of chromosome 5. (1989) (66)
The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. (1993) (65)
The Ig kappa L chain allelic groups among the Ig kappa haplotypes and Ig kappa crossover populations suggest a gene order. (1988) (64)
Gene mapping of the three subunits of the high affinity FcR for IgE to mouse chromosomes 1 and 19. (1989) (61)
Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. (1994) (57)
The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. (1996) (55)
GENETIC CONTROL OF LEISHMANIA MAJOR INFECTION IN CONGENIC, RECOMBINANT INBRED AND F2 POPULATIONS OF MICE (1993) (52)
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. (2011) (51)
Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene (1994) (47)
A mouse homeo box gene, Hox-1.5, and the morphological locus, Hd, map to within 1 cM on chromosome 6. (1987) (45)
The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription (2019) (44)
Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization. (1991) (42)
Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice (1987) (42)
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells (2017) (41)
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. (2009) (40)
A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus. (1990) (36)
Multigenic control of skin tumor susceptibility in SENCARA/Pt mice. (1998) (34)
Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene (2003) (33)
The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. (1997) (33)
A linkage map of mouse Chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation (2004) (29)
Genes on chromosomes 1 and 4 in the mouse are associated with repair of radiation-induced chromatin damage. (1988) (28)
Receptors for Fc epsilon and Fc gamma are linked on mouse chromosome 1. (1988) (27)
Mapping of the bcl-2 oncogene on mouse chromosome 1. (1988) (27)
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms (2014) (26)
1. The Environmental Component of Evolutionary Biology (1983) (26)
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation (2017) (25)
New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin (1997) (24)
Cdkn 2 a , the cyclin-dependent kinase inhibitor encoding p 16 INK 4 a and p 19 ARF , is a candidate for the plasmacytoma susceptibility locus , Pctr 1 (1998) (21)
Construction of a series of congenic mice with recombinant chromosome 1 regions surrounding the genetic loci for resistance to intracellular parasites (Ity, Lsh, and Bcg), DNA repair responses (Rep-1), and the cytoskeletal protein villin (Vil) (1994) (21)
Gene organization and chromosome location of the neural-specific RNA binding protein Elavl4. (1998) (20)
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity. (2014) (20)
Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. (1995) (20)
Genetic control of systemic Leishmania major infection: identification of subline differences for susceptibility to disease. (1985) (18)
Characterization of clinically used oral antiseptics as quadruplex-binding ligands (2018) (17)
Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10. (1996) (17)
Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy (2015) (17)
A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma (2020) (17)
Genetic control of systemic Leishmania major infections: dissociation of intrahepatic amastigote replication from control by the Lsh gene (1985) (15)
cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma (2017) (14)
Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1. (1996) (14)
An Nramp-related sequence maps to mouse Chromosome 17 (1994) (13)
Organization of the distal end of mouse chromosome 4. (1988) (12)
The Role of Plasmacytoma Growth Factor in the in Vitro Responses of Murine Plasmacytoma Cells (1989) (12)
Mouse chromosome 15 (2004) (11)
The organization of the immunoglobulin kappa locus in mice. (1988) (11)
A molecular characterization of BALB/c congenic C.D2-Idh-1b, Lshr, Rep-1b, Pep-3b mice. (1988) (9)
Mouse chromosome 4 (2004) (9)
The gene for Lap18, leukemia-associated phosphoprotein p18 (metablastin), maps to distal mouse Chromosome 4 (2004) (8)
A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses. (2013) (8)
The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility (2019) (8)
The infrapopulation dynamics of trypanosomes in red-spotted newts (1984) (7)
The gene for mouse p58cdc2L1 (Cdc2l1) protein kinase maps to distal mouse Chromosome 4 (1994) (7)
T-cell receptor VTβ genes in natural populations of mice (2004) (7)
Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice (2022) (7)
The role of p16INK4a (Cdkn2a) in mouse plasma cell tumors. (1999) (7)
Longitudinal patterns of trypanosome infections in red-spotted newts. (1987) (7)
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis (2020) (6)
The effect of the nude gene on plasmacytoma development in BALB/cAn mice. (1988) (6)
A restriction fragment length polymorphism at murine Glud locus co-segregates with Rib-1, Es-10, and Tcra on chromosome 14. (1989) (5)
A restriction fragment length polymorphism at the murine c-myb locus. (1987) (5)
Encyclopedia of the mouse genome V. Mouse chromosome 4. (1996) (5)
Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress (2021) (5)
Attenuation of immune‐mediated bone marrow damage in conventionally housed mice (2020) (5)
Susceptibility and resistance to plasmacytomagenesis: possible role of genes that modify efficiency of chromatin repair. (1988) (5)
Mapping of the Ly-4 (L3T4) T-cell differentiation antigen on mouse chromosome 6 by the use of RFLPs in an interspecific cross (2004) (5)
Mouse chromosome 4 (2009) (5)
mTORC 1 and mTORC 2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells (2011) (5)
Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression (2020) (5)
WDR26 and MTF2 are therapeutic targets in multiple myeloma (2021) (4)
The Reign of Antibodies: A Celebration of and Tribute to Michael Potter and His Homogeneous Immunoglobulin Workshops (2018) (4)
The genetics of susceptibility to RIM-induced plasmacytomagenesis. (1988) (4)
A comparison of genetic linkage maps surrounding the Lsh/Ity/Bcg disease resistance locus. (1989) (4)
Mouse chromosome 4 (2004) (4)
Molecular cloning, chromosomal mapping, and expression of the mouse p107 gene (1996) (3)
Structure and localization of mouse Pmscl1 and Pmscl2 genes. (2000) (3)
All About Mice. (Book Reviews: Mouse Genetics. Concepts and Applications) (1995) (3)
Immunoprophylaxis in BALB/c mice: a model for development of protection against primary and secondary infection with Leishmania major. (1985) (3)
A TaqI restriction fragment length polymorphism at the Hox-2.1 locus cosegregates with the Dlb-1 locus on mouse chromosome 11. (1987) (3)
T-cell receptor VT beta genes in natural populations of mice. (1988) (3)
Encyclopedia of the mouse genome V. Mouse chromosome 15. (1996) (3)
Mouse genetics 2011: meeting report (2012) (2)
Associated with Genetic Resistance to Bacterial Infection (1989) (2)
Isolation and mapping of four new DNA markers from mouse Chromosome 4 (1992) (2)
Combined use of HDAC and mTOR inhibitors has synergistic effect on inhibiting B-cell tumor cell lines (2007) (1)
Riz maps to distal Chromosome 4 near genes involved in tumorigenesis and nerve degeneration (1996) (1)
The 2000 Chromosome Committee Reports for the Mouse Genome (2000) (1)
Genetics of Immunological Diseases (1988) (1)
Regulation of macrophage antimicrobial activities by lymphocyte products (1986) (1)
Mouse Chromosome 15 (2004) (1)
A Novel Therapeutic Treatment Utilizing Cordycepin and Cladribine Synergy to Decrease Adverse Treatment Effects in Various Cancer Cell Lines (2013) (1)
Mouse tumor susceptibility genes identify drug combinations for multiple myeloma (2020) (1)
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer (2021) (1)
Abstract A73: De-convoluting therapeutic resistance in a pancreatic cancer model: Pharmacogenomic evaluation of intratumoral clonal heterogeneity (2015) (1)
Encyclopedia of the mouse genome III. October 1993. Mouse chromosome 15. (1993) (1)
development, and antibody production Constitutive reductions in mTOR alter cell size, immune cell (2011) (1)
Conditional deletion of mTOR discloses its essential role in early B‐cell development (2021) (1)
MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia. (1997) (1)
Encyclopedia of the mouse genome VII. Mouse chromosome 4. (1998) (1)
Abstract 5472: Systems pharmacogenomics approach identifies synergistic molecular action of combined MTOR/HDAC inhibition on MYC (2014) (0)
Hormonal Modulation ofSexDifferences inResistance to Leishmania majorSystemic Infections (1988) (0)
Abstract C111: Genes cooperatively targeted by combined mTOR/histone deactylase (HDAC) inhibition are predictive of increased multiple myeloma patient survival. (2011) (0)
Abstract 2217: A systems pharmacogenomic approach to identify synergistic molecular mechanisms of combined mTOR/HDAC inhibition. (2013) (0)
Abstract 5113: A flexible pipeline for precision medicine biomarker detection and prediction of treatment response (2019) (0)
Abstract 2309: Murine model of dual mTORC kinase inhibition identifies CDK6 as a synergistic target in T-ALL (2015) (0)
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs. (2023) (0)
All About Mice: Mouse Genetics. Concepts and Applications . Lee M. Silver. Oxford University Press, New York, 1995. xiv, 362 pp., illus. $49.95 or £40. (1995) (0)
Abstract B40: Selective suppression of Myc transcription with a G-quadruplex stabilizing small molecule (2015) (0)
From Phenotype to Gene: A Molecular Analysis of Complex Loci Involved in Developmental and Immunological Dysregulation (1988) (0)
B cell development (WS-030) Chairpersons: Daisuke Kitamura, David Gray (2010) (0)
Abstract 5328: mTOR inhibitor enhances anti-tumor effect of BET bromodomain inhibitor in small cell lung cancer (2020) (0)
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex (2018) (0)
Mouse genetics 2011: meeting report (2012) (0)
Abstract 805: mTORC protein levels affect class switch recombination, somatic hypermutation, and antibody production (2011) (0)
The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription (2019) (0)
Abstract 5850: Nrf2-mediated oxidative stress response is altered during acquired resistance to the proteasome inhibitor, oprozomib, in multiple myeloma (2018) (0)
Cover Image, Volume 59, Issue 2 (2020) (0)
Mouse chromosome 4 (1996) (0)
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells (2017) (0)
Mouse Chromosome 4 (1999) (0)
Encyclopedia of the mouse genome III. October 1993. Mouse chromosome 4. (1993) (0)
HES1, a bHLH Transcription Factor Regulate Cell Proliferation and Promotes Apoptosis in Multiple Myeloma Cells (2017) (0)
Abstract 4734: Genes cooperatively downregulated by combined mTOR/histone deactylase (HDAC) inhibition are overexpressed in myeloma patients with lower survival (2012) (0)
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance. (2023) (0)
Mouse chromosome 15 (2004) (0)
Abstract 2833: Genetic and pharmacologic inhibition of mTOR delays mortality due to thymc lymphoma formation in mice and is associated with decreases in cell cycle proteins (2016) (0)
Mouse Chromosome 4 (2004) (0)
Abstract 194: Effective targeting of MYC expression with a novel nucleic acid binding (G4-quadruplex) small molecule coupled with HDAC inhibition synergizes to limit myeloma growth (2017) (0)
Abstract LB-74: A high-throughput RNAi sensitization screen of rapamycin identifies targets for rational drug combination strategies (2010) (0)
Abstract 1555: Use of a mouse model of constitutive mTOR inhibition to identify molecular modulators of acquired resistance. (2013) (0)
Chromosomal Translocation Chromosomal Translocation Mechanisms and Consequences of Mechanisms and Consequences of (2006) (0)
Abstract 4408: A functional genomics approach for identification of sirolimus sensitizer genes regulated by HDAC inhibitors. (2013) (0)
Abstract 1629: Identification and biological characterization of a novel class of small molecules to inhibit c-myc transcription (2014) (0)
Abstract 322: Selective inhibition of MYC expression by a small molecule G-quadruplex stabilizer (2016) (0)
Abstract 5310: mTOR knock-down mice exhibit altered T and B cell activation, differentiation and immune response (2010) (0)
Abstract PR6: A cooperative molecular response to combined mTOR/HDAC inhibition revealed by transcriptional co-expression analysis (2012) (0)

This paper list is powered by the following services:

Other Resources About Beverly Mock

en.wikipedia.org

What Schools Are Affiliated With Beverly Mock?

Beverly Mock is affiliated with the following schools: